UNITED THERAPEUTICS Corp (UTHR) Financial Statements (2026 and earlier)

Company Profile

Business Address 1000 SPRING ST
SILVER SPRING, MD 20910
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

6/30/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3,2672,9942,8391,9311,8351,486
Cash and cash equivalent1,6971,208961895739738
Short-term investments1,5701,7861,8781,0361,096748
Receivables279279220199157151
Inventory, net of allowances, customer advances and progress billings158112102948793
Inventory158112102948793
Other current assets17016621910088134
Total current assets:3,8743,5513,3802,3242,1671,865
Noncurrent Assets
Property, plant and equipment1,2221,045862781732739
Long-term investments and receivables1,4751,9101,3161,6501,150768
Long-term investments1,4751,9101,3161,6501,150768
Intangible assets, net (including goodwill), including:1121144545158158
Goodwill 323428282828
Intangible assets, net (excluding goodwill) (7)(6)(6)(6)(6)(5)
Other undisclosed intangible assets, net (including goodwill)87872222136136
Deferred income tax assets458395328262239230
Other noncurrent assets222152114108170155
Total noncurrent assets:3,4903,6162,6642,8462,4482,049
TOTAL ASSETS:7,3647,1676,0455,1694,6153,913
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities345298230175187148
Accounts payable 6644410
Accrued liabilities 339292226171183139
Other undisclosed accounts payable and accrued liabilities      
Debt 300400   252
Other liabilities837133284040
Other undisclosed current liabilities 1135811029723
Total current liabilities:738804343305323463
Noncurrent Liabilities
Long-term debt and lease obligation  300800800800600
Long-term debt, excluding current maturities  300800800800600
Liabilities, other than long-term debt182781051059770
Other liabilities182781051059770
Total noncurrent liabilities:182378905905897670
Total liabilities:9201,1821,2481,2101,2201,133
Equity
Equity, attributable to parent6,4445,9854,7973,9593,3952,780
Common stock111111
Treasury stock, value(3,475)(2,579)(2,579)(2,579)(2,579)(2,579)
Additional paid in capital2,6992,5492,3882,2452,1492,048
Accumulated other comprehensive loss (3)(13)(56)(23)(14)(14)
Retained earnings7,2226,0275,0424,3153,8393,325
Total equity:6,4445,9854,7973,9593,3952,780
TOTAL LIABILITIES AND EQUITY:7,3647,1676,0455,1694,6153,913

Income Statement (P&L) ($ in millions)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues2,8772,3281,9361,6861,4831,449
Cost of revenue(310)(258)(634)(590)(359)(391)
Cost of product and service sold(310)(258)(152)(123)(108)(118)
Other undisclosed gross profit   482467  
Gross profit:2,5682,0701,7851,5631,1241,058
Operating expenses(1,191)(885)(323)(540)(531)(1,245)
Other undisclosed operating loss   (482)(467)  
Operating income (loss):1,3771,185980556594(188)
Nonoperating income (expense)16289(29)384523
Investment income, nonoperating19916345172944
Other nonoperating income (expense)6(14)(40)424923
Interest and debt expense(43)(59)(32)(19)(24)(44)
Income (loss) from continuing operations before equity method investments, income taxes:1,4961,215918575615(209)
Other undisclosed income from continuing operations before income taxes435932192444
Income (loss) from continuing operations before income taxes:1,5391,274951594639(165)
Income tax expense (benefit)(344)(290)(223)(118)(124)61
Income (loss) from continuing operations:1,195985727476515(105)
Income (loss) before gain (loss) on sale of properties:476515(105)
Net income (loss) available to common stockholders, diluted:1,195985727476515(105)

Comprehensive Income ($ in millions)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net income (loss):1,195985727476515(105)
Other comprehensive income (loss) (5)(3)196  
Other undisclosed comprehensive loss      
Comprehensive income (loss):1,190982747482515(105)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent1446(52)(15) (6)
Comprehensive income (loss), net of tax, attributable to parent:1,2051,028695467515(111)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: